期刊文献+

葛根素对雷帕霉素造成人脐静脉内皮细胞损伤的影响

Puerarin protects the human vascular endothelial cells induced by rapamycin in vitro
原文传递
导出
摘要 目的:探讨葛根素对雷帕霉素造成人脐静脉内皮细胞(HUVEC)损伤的影响及其可能机制。方法:培养HUVEC并分组:对照组,葛根素组,雷帕霉素组,葛根素干预组。各组培养48h后,检测各组HUVEC的增殖,NO浓度及凋亡率的情况。结果:与对照组比较,葛根素组NO浓度明显升高(P<0.05),HUVEC凋亡率明显降低(P<0.01);葛根素干预组NO浓度明显降低(P<0.01);雷帕霉素组可抑制HUVEC增殖,NO浓度明显降低,HUVEC凋亡率明显升高(P<0.01)。与雷帕霉素比较,葛根素组NO浓度明显升高,HUVEC凋亡率明显降低(P<0.01);葛根素干预组促进HUVEC增殖,NO浓度明显升高,HUVEC凋亡率明显降低(P<0.05,P<0.01)。结论:葛根素对雷帕霉素造成HUVEC损伤具有一定的拮抗作用。 Objective:To study the effect of puerarin on injury of human vascular endothelial cells(HUVEC)induced by rapamycin in vitro and to explore its regulation mechanisms.Method:The HUVEC were cultured and divided into four groups:normal group,puerarin group,rapamycin group and puerarin pretreat group.After 48 h culture,the proliferation of HUVEC,the level of NO,and the rate of apoptosis were detected.Result:Compared with normal group,NO levels were significantly increased in puerarin group(P〈0.05),meanwhile,the rate of apoptosis was deceased(P〈0.01);however,NO levels were markedly reduced in puerarin pretreat group(P〈0.01).Rapamycin inhibited the proliferation of HUVEC,reduced NO levels but increased the rate of apoptosis(P〈0.01).Compared with rapamycin group,the cells treated with puerarin had higher level of NO and proliferation but lower rate of apoptosis(P〈0.01).Conclusion:Puerarin can attenuate HUVEC injury induced by rapamycin.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2016年第4期381-383,共3页 Journal of Clinical Cardiology
关键词 葛根素 雷帕霉素 人脐静脉内皮细胞 拮抗 puerarin rapamycin human vascular endothelial cells antagonistic effect
作者简介 通信作者:刘兆英,E—mail:13953910708@163.com
  • 相关文献

参考文献8

  • 1JAKABCIN J,BYSTRON M,SPACEK R,et al.The lack of endothelization after drug-eluting stent implantation as a cause of fatal late stent thrombosis[J].J Thromb Thrombolysis,2008,26:154-158.
  • 2张颖,殷惠军.植物雌激素的心血管保护作用研究进展[J].中华老年心脑血管病杂志,2012,14(9):991-994. 被引量:5
  • 3魏述永.葛根素心血管保护作用及其机制研究进展[J].中国中药杂志,2015,40(12):2278-2284. 被引量:66
  • 4KANEKO H,KIJIMA M.Role of bare-metal stents for left main coronary artery disease in the era of drugeluting stents.-Which coronary stent should be used for left main trunk disease?BMS or DES?(BMS-side)[J].Circ J,2011,75:1243-1249.
  • 5NOTARISTEFANO S,SBARZAGLIA P,CAVALLINI C.Late stent thrombosis after drug-eluting stent implantation:epidemiological,clinical and pathophysiological aspects[J].G Ital Cardiol(Rome),2008,9:674-683.
  • 6BAO M H,ZHANG Y W,LOU X Y,et al.Puerarin protects endothelial cells from oxidized low density lipoprotein induced injuries via the suppression of LOX-1and induction of eNOS[J].Can J Physiol Pharmacol,2014,92:299-306.
  • 7ZHANG J,GUO W,TIAN B,et al.Puerarin attenuates cognitive dysfunction and oxidative stress in vascular dementia rats induced by chronic ischemia[J].Int J Clin Exp Pathol,2015,8:4695-704.
  • 8PAPAFAKLIS M I,CHATZIZISIS Y S,NAKA K K,et al.Drug-eluting stent restenosis:effect of drug type,release kinetics,hemodynamics and coating strategy[J].Pharmacol Ther,2012,134:43-53.

二级参考文献59

共引文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部